146 related articles for article (PubMed ID: 4042418)
1. MRL mice show an age-related impairment of IgG aggregate removal from the circulation.
Field M; Brennan FM; Melsom RD; McCarthy D; Mumford P; Maini RN
Clin Exp Immunol; 1985 Jul; 61(1):195-202. PubMed ID: 4042418
[TBL] [Abstract][Full Text] [Related]
2. MRL-lpr/lpr mice show an impairment of IgG aggregate removal which relates to parameters of disease activity.
Field M; Brennan FM; McCarthy D; Mumford P; Maini RN
Immunology; 1987 Aug; 61(4):463-7. PubMed ID: 3443452
[TBL] [Abstract][Full Text] [Related]
3. Hepatic reticuloendothelial system activation in autoimmune mice: differences between (NZB X NZW)F1 and MRL-lpr/lpr strains.
Magilavy DB; Hundley TR; Steinberg AD; Katona IM
Clin Immunol Immunopathol; 1987 Mar; 42(3):386-98. PubMed ID: 3030589
[TBL] [Abstract][Full Text] [Related]
4. Defects in mononuclear phagocytic system (MPS) function in autoimmune MRL-lpr/lpr mice.
Jones FS; Pisetsky DS; Kurlander RJ
Clin Immunol Immunopathol; 1985 Jul; 36(1):30-9. PubMed ID: 3874027
[TBL] [Abstract][Full Text] [Related]
5. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
6. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
Meryhew NL; Shaver C; Messner RP; Runquist OA
J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
[TBL] [Abstract][Full Text] [Related]
7. IgG anti-cardiolipin antibodies in murine lupus.
Gharavi AE; Mellors RC; Elkon KB
Clin Exp Immunol; 1989 Nov; 78(2):233-8. PubMed ID: 12412755
[TBL] [Abstract][Full Text] [Related]
8. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice.
Shear HL; Wofsy D; Talal N
Clin Immunol Immunopathol; 1983 Mar; 26(3):361-9. PubMed ID: 6872348
[TBL] [Abstract][Full Text] [Related]
9. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic properties of synthetic fragments of Sm-D protein in normal and lupus mice.
Winska-Wiloch H; Muller S; Katz DR; Wilkinson L; Hutchings PR; Isenberg DA
Lupus; 1997; 6(8):656-67. PubMed ID: 9364425
[TBL] [Abstract][Full Text] [Related]
11. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
[TBL] [Abstract][Full Text] [Related]
12. Elevated production of interleukin 6 by hepatic MNC correlates with ICAM-1 expression on the hepatic sinusoidal endothelial cells in autoimmune MRL/lpr mice.
Ohteki T; Okamoto S; Nakamura M; Nemoto E; Kumagai K
Immunol Lett; 1993 May; 36(2):145-52. PubMed ID: 8102352
[TBL] [Abstract][Full Text] [Related]
13. The liver of MRL/lpr mice contains defective accessory cells and a population of immunosuppressive lymphocytes.
Magilavy DB; Rowley DA; Davis M
Cell Immunol; 1990 Feb; 125(2):469-79. PubMed ID: 2137036
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 is a proliferative signal for B cells from autoimmune mice.
Lehmann KR; Kotzin BL; Portanova JP; Santoro TJ
Eur J Immunol; 1986 Sep; 16(9):1105-10. PubMed ID: 3093246
[TBL] [Abstract][Full Text] [Related]
15. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice.
Mizuochi T; Hamako J; Nose M; Titani K
J Immunol; 1990 Sep; 145(6):1794-8. PubMed ID: 2391420
[TBL] [Abstract][Full Text] [Related]
16. Nephritogenicity of the lprcg gene on the MRL background.
Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
Makino M; Fujiwara M; Watanabe H
J Clin Lab Immunol; 1988 Feb; 25(2):83-8. PubMed ID: 3259631
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
19. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
